Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 112Lymphoma 66Lymphoma, Large B-Cell, Diffuse 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 29Lymphoma, Follicular 22Burkitt Lymphoma 22Multiple Myeloma 19Leukemia 16Hodgkin Disease 16Neoplasms 14Neoplasm Metastasis 13Lymphoma, B-Cell 13Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Anaplastic 11Lymphoma, T-Cell 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, T-Cell, Peripheral 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, AIDS-Related 4Immunoblastic Lymphadenopathy 4Prostate Cancer Metastatic 3Primary Myelofibrosis 3Polycythemia Vera 3Plasmablastic Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3

Interventions

Vincristine 1VGX-3100 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × HIV Seropositivity × Prednisone × Clear all
NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
194 enrolled 19 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡